Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Undiscovered Gems in Hong Kong to Explore This September 2024

In This Article:

As global markets face heightened volatility and economic uncertainties, the Hong Kong market has shown resilience, particularly in its small-cap segment. Amidst this backdrop, investors may find opportunities in lesser-known stocks that demonstrate strong fundamentals and growth potential. In this environment, identifying a good stock involves looking for companies with solid financial health, innovative business models, and a clear path to profitability.

Top 10 Undiscovered Gems With Strong Fundamentals In Hong Kong

Name

Debt To Equity

Revenue Growth

Earnings Growth

Health Rating

Lion Rock Group

16.91%

14.33%

10.15%

★★★★★★

Changjiu Holdings

NA

11.84%

2.46%

★★★★★★

Sundart Holdings

0.92%

-2.32%

-3.94%

★★★★★★

China Leon Inspection Holding

8.55%

21.36%

22.77%

★★★★★★

Tianyun International Holdings

10.09%

-5.59%

-9.92%

★★★★★★

Chongqing Machinery & Electric

28.07%

8.82%

11.12%

★★★★★☆

HBM Holdings

52.89%

66.59%

31.70%

★★★★★☆

TIL Enviro

47.97%

-23.09%

-8.84%

★★★★☆☆

Pizu Group Holdings

48.34%

-4.53%

-19.78%

★★★★☆☆

Billion Industrial Holdings

3.63%

18.00%

-11.38%

★★★★☆☆

Click here to see the full list of 173 stocks from our SEHK Undiscovered Gems With Strong Fundamentals screener.

Let's uncover some gems from our specialized screener.

IVD Medical Holding

Simply Wall St Value Rating: ★★★★★☆

Overview: IVD Medical Holding Limited, with a market cap of HK$2.13 billion, is an investment holding company that distributes in vitro diagnostic (IVD) products in Mainland China and internationally.

Operations: IVD Medical Holding generates revenue primarily from its distribution business (CN¥2.86 billion) and after-sales services (CN¥196.47 million), with a smaller contribution from self-branded products (CN¥9.05 million).

IVD Medical Holding, a small cap in Hong Kong's healthcare sector, reported earnings growth of 12.3% over the past year, surpassing the industry average of -11.6%. For the first half of 2024, sales reached CNY 1.35 billion while net income stood at CNY 125.29 million. The company repurchased shares worth HKD 189.64 million recently and has a net profit margin of around 9%. Despite some volatility in its share price over the past three months, IVD Medical continues to show robust financial health and potential for future growth.

SEHK:1931 Debt to Equity as at Sep 2024
SEHK:1931 Debt to Equity as at Sep 2024

YesAsia Holdings

Simply Wall St Value Rating: ★★★★★★

Overview: YesAsia Holdings Limited (SEHK:2209) is an investment holding company involved in the procurement, sale, and trading of Asian fashion and lifestyle, beauty, cosmetics, accessories, and entertainment products with a market cap of approximately HK$2.47 billion.